Golden logoGolden logo
Advanced Search
Johnson & Johnson Innovation

Johnson & Johnson Innovation

Johnson & Johnson Innovation is a division of Johnson & Johnson Finance Corporation. Johnson & Johnson Innovation focuses on accelerating early innovation for global healthcare businesses.

Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies focused on early-stage opportunities access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and diagnostics and consumer companies of Johnson & Johnson.

In June 2013, Johnson & Johnson Innovation announced the opening of the Johnson & Johnson California Innovation Center, one of four regional hubs being established. A part of Johnson & Johnson Innovation, the goal of the California Innovation Center is to advance healthcare by catalyzing collaborations in science and technology between regional innovators and the Johnson & Johnson Family of Companies.

In March 2015, Johnson & Johnson Innovation LLC announced the opening of JLABS in South San Francisco. The Johnson & Johnson Innovation, JLABS site can accommodate up to 50 startups from across the healthcare spectrum including biotech, pharmaceutical, medical device, consumer and digital health.

JLABS provides tools and resources to help life science startups. Residents have access to infrastructure as well as year-round commercialization curriculum and networking events, onsite team for operations and business services. JLABS links regional entrepreneurs with the full breadth of Johnson & Johnson Innovation, including opportunities to discuss funding, access third-party services, attend educational events and meet with R&D experts from medical device technology, consumer healthcare product and Janssen pharmaceutical teams.

In June 2018, Johnson & Johnson Innovation's outpost of its startup incubator, JLabs, opened in Manhattan . In addition to NYC, there are JLabs in San Diego, San Francisco, Toronto, Houston, Boston and Belgium as well as another planned in Shanghai. The incubators provide J&J, one of the largest pharmaceutical companies in the world, with a view of what's happening at the startup level. Though J&J doesn't take an immediate stake in the companies, it does end up investing in some in the long-run.


Invested in


Funding Rounds Participated In

Further Resources



July 16, 2021
Johnson & Johnson Innovation announced the extension of the Johnson & Johnson Innovation Partnering Office at Monash University's Clayton Campus in Melbourne (JJIPO@Monash) in collaboration with the Victorian State Government. This joint initiative between Johnson & Johnson Innovation, the Victorian Government and Monash University will be extended for approximately two years through June 30, 2023. The agreement will allow JJIPO@Monash to continue connecting with the Victorian innovation...
April 22, 2021
/PRNewswire/ -- BioNJ's Eleventh Annual BioPartnering Conference scheduled for Tuesday, May 18 and Wednesday, May 19, will bring together life sciences...
Johnson & Johnson Innovation
November 24, 2020
/PRNewswire/ -- Janssen Korea Ltd. and Johnson & Johnson Innovation LLC today, in collaboration with the Seoul Metropolitan Government (SMG) and Korea Health...
Heather Landi
August 17, 2020
Johnson & Johnson is investing in direct-to-consumer telehealth company Thirty Madison. The New York City-based startup offers telehealth visits and online prescriptions for drugs for hair loss, migraines and acid reflux. Here's why the pharmaceutical giant is backing the telehealth company.
June 13, 2020
The Pulse of New York Tech


Golden logo
By using this site, you agree to our Terms of Service.